Xenetic Biosciences, Inc. (XBIO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 806.92K | 766.3K | 1.03M | 589.9K | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651K | 605.84K | 486.97K | 414.25K | 416.71K | 388.99K | 332.6K | 349.27K | 287.6K |
| Revenue Growth % | 36.01% | 18.11% | 67.19% | -18.79% | 16.14% | -3.44% | 0.5% | 11.58% | -15.69% | 37.99% | 47.54% | 56.23% | 55.75% | 46.41% | 18.6% | 44.89% | 103.43% | 119.78% | 201.27% | 154.68% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.96K | 0 | 0 | 9.28K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.92% | - | - | 2.79% | - | - |
| Gross Profit | 0 | 766.3K | 1.03M | 589.9K | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651K | 605.84K | 486.97K | 406.29K | 416.71K | 388.99K | 323.32K | 349.27K | 287.6K |
| Gross Margin % | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 98.08% | 100% | 100% | 97.21% | 100% | 100% |
| Gross Profit Growth % | -100% | 18.11% | 67.19% | -18.79% | 16.14% | -3.44% | 0.5% | 11.58% | -15.69% | 37.99% | 50.43% | 56.23% | 55.75% | 50.62% | 16.33% | 44.89% | 103.43% | 113.65% | 201.27% | 154.68% |
| Operating Expenses | 1.31M | 1.39M | 1.57M | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M | 1.78M | 1.93M | 1.76M | 1.85M | 1.52M | 2.05M | 1.25M | 3.1M | 2.01M | 2.2M | 1.73M | 1.42M |
| OpEx % of Revenue | 162.23% | 181.3% | 153.04% | 222.8% | 258.85% | 269.41% | 181.32% | 284.11% | 348.31% | 286.87% | 287.62% | 284.05% | 251.06% | 421.03% | 302.74% | 744.83% | 516.39% | 660.65% | 493.97% | 492.09% |
| Selling, General & Admin | 647.6K | 615.91K | 815.21K | 657.75K | 656.64K | 705.71K | 745.73K | 1.13M | 834.91K | 952K | 737.24K | 945.95K | 925.74K | 857.17K | 855.28K | 1.03M | 907.31K | 968.29K | 945.12K | 890.7K |
| SG&A % of Revenue | 80.26% | 80.37% | 79.38% | 111.5% | 110.68% | 108.77% | 121.41% | 155.56% | 163.45% | 141.67% | 120.63% | 145.31% | 152.8% | 176.02% | 206.46% | 246.28% | 233.25% | 291.12% | 270.6% | 309.7% |
| Research & Development | 661.44K | 773.42K | 756.48K | 656.56K | 879.03K | 1.04M | 367.99K | 933.77K | 944.32K | 975.63K | 1.02M | 903.24K | 595.28K | 1.68M | 398.8K | 2.08M | 1.1M | 1.23M | 780.15K | 524.55K |
| R&D % of Revenue | 81.97% | 100.93% | 73.66% | 111.3% | 148.17% | 160.64% | 59.91% | 128.55% | 184.87% | 145.19% | 166.99% | 138.75% | 98.26% | 345.38% | 96.27% | 498.55% | 283.14% | 369.52% | 223.37% | 182.39% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -488.75K | 0 | 1 | 0 | 0 | 0 | 0 |
| Operating Income | -502.12K | -623.03K | -544.73K | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.17K | -1.56M | -847.79K | -2.69M | -1.62M | -1.87M | -1.38M | -1.13M |
| Operating Margin % | -62.23% | -81.3% | -53.04% | -122.8% | -158.85% | -169.41% | -81.32% | -184.11% | -248.31% | -186.87% | -187.62% | -184.05% | -151.06% | -321.03% | -204.66% | -644.83% | -416.39% | -563.44% | -393.97% | -392.09% |
| Operating Income Growth % | 46.72% | 43.32% | -9.06% | 45.83% | 25.7% | 12.47% | 56.44% | -11.62% | -38.6% | 19.68% | -35.26% | 55.41% | 43.5% | 16.58% | 38.39% | -138.29% | -18.31% | -53.61% | 86.9% | -14.78% |
| EBITDA | -502.12K | -623.03K | -557.97K | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.28M | -1.26M | -1.14M | -1.2M | -902.26K | -1.55M | -839.83K | -2.68M | -1.61M | -1.86M | -1.37M | -1.12M |
| EBITDA Margin % | -62.23% | -81.3% | -54.33% | -122.8% | -158.85% | -169.41% | -81.32% | -184.11% | -250.39% | -188.03% | -186.37% | -183.61% | -148.93% | -317.29% | -202.74% | -642.73% | -413.95% | -560.65% | -391.38% | -389.04% |
| EBITDA Growth % | 46.72% | 43.32% | -11.71% | 45.83% | 26.32% | 13.01% | 56.15% | -11.88% | -41.76% | 18.23% | -35.63% | 55.37% | 43.97% | 17.14% | 38.56% | -139.37% | -18.34% | -52.85% | 86.98% | -14.72% |
| D&A (Non-Cash Add-back) | 0 | 0 | -13.24K | 0 | 0 | 0 | 0 | 0 | -10.62K | -7.85K | 7.64K | 2.86K | 12.92K | 18.2K | 7.96K | 8.77K | 9.47K | 9.28K | 9.04K | 8.75K |
| EBIT | -502.12K | -623.03K | -509.94K | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.17K | -1.56M | -804.02K | -2.69M | -1.62M | -1.84M | -1.38M | -1.13M |
| Net Interest Income | 45.76K | 43.79K | 30.78K | 34.23K | 39.19K | 51.87K | 61.3K | 63.45K | 73.25K | 83.76K | 91.8K | 126.1K | 54.1K | 79.81K | 45.48K | 15.96K | 25.91K | 29.44K | 28.03K | 20.73K |
| Interest Income | 45.76K | 43.79K | 30.78K | 34.23K | 39.19K | 51.87K | 61.3K | 63.45K | 73.25K | 83.76K | 91.8K | 126.1K | 54.1K | 79.81K | 45.48K | 15.96K | 25.91K | 29.44K | 28.03K | 20.73K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 45.73K | 43.95K | 34.8K | 35.71K | 39.27K | 44.62K | 62.8K | 63.43K | 73.3K | 84.16K | 91.13K | 147.22K | 58.62K | 80.79K | 43.77K | 14.89K | 26.1K | 32.34K | 25.12K | 20.97K |
| Pretax Income | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M |
| Pretax Margin % | -56.56% | -75.57% | -49.66% | -116.75% | -152.23% | -162.53% | -71.09% | -175.38% | -233.96% | -174.34% | -172.71% | -161.44% | -141.38% | -304.44% | -194.09% | -641.26% | -409.68% | -553.72% | -386.77% | -384.79% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M |
| Net Margin % | -56.56% | -75.57% | -49.66% | -116.75% | -152.23% | -162.53% | -71.09% | -175.38% | -233.96% | -174.34% | -172.71% | -161.44% | -141.38% | -304.44% | -194.09% | -641.26% | -409.68% | -553.72% | -386.77% | -384.79% |
| Net Income Growth % | 49.47% | 45.09% | -16.78% | 45.94% | 24.43% | 9.99% | 58.63% | -21.22% | -39.53% | 20.98% | -31.29% | 60.67% | 46.25% | 19.5% | 40.48% | -141.46% | -18.4% | -53.47% | 82.13% | -16.05% |
| Net Income (Continuing) | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -0.25 | -0.33 | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.60 | -2.08 | -1.21 | -1.80 | -1.33 | -1.27 |
| EPS Growth % | 66.1% | 63.24% | -17.86% | 45.78% | 24.36% | 10.53% | 59.42% | -20.29% | -47.17% | 16.48% | -15% | 66.83% | 56.2% | 49.44% | 54.89% | -63.78% | 21.43% | -13.21% | 88.93% | 16.45% |
| EPS (Basic) | -0.20 | -0.25 | -0.33 | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.60 | -2.08 | -1.21 | -1.80 | -1.33 | -1.30 |
| Diluted Shares Outstanding | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 874.67K |
| Basic Shares Outstanding | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 851.29K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |